284 related articles for article (PubMed ID: 29915918)
1. Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD.
von der Burchard C; Treumer F; Ehlken C; Koinzer S; Purtskhvanidze K; Tode J; Roider J
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1623-1629. PubMed ID: 29915918
[TBL] [Abstract][Full Text] [Related]
2. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration.
Schmidt-Erfurth U; Vogl WD; Jampol LM; Bogunović H
Ophthalmology; 2020 Sep; 127(9):1211-1219. PubMed ID: 32327254
[TBL] [Abstract][Full Text] [Related]
3. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
[TBL] [Abstract][Full Text] [Related]
5. Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.
Keenan TDL; Chakravarthy U; Loewenstein A; Chew EY; Schmidt-Erfurth U
Am J Ophthalmol; 2021 Apr; 224():267-281. PubMed ID: 33359681
[TBL] [Abstract][Full Text] [Related]
6. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB
Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500
[TBL] [Abstract][Full Text] [Related]
7. The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.
Arnold JJ; Markey CM; Kurstjens NP; Guymer RH
BMC Ophthalmol; 2016 Mar; 16():31. PubMed ID: 27009515
[TBL] [Abstract][Full Text] [Related]
8. Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activity.
Major JC; Wykoff CC; Mariani AF; Chen E; Croft DE; Brown DM
Retina; 2014 Jan; 34(1):48-54. PubMed ID: 23764967
[TBL] [Abstract][Full Text] [Related]
9. Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.
Waldstein SM; Simader C; Staurenghi G; Chong NV; Mitchell P; Jaffe GJ; Lu C; Katz TA; Schmidt-Erfurth U
Ophthalmology; 2016 Jul; 123(7):1521-9. PubMed ID: 27157149
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy.
Golbaz I; Ahlers C; Stock G; Schütze C; Schriefl S; Schlanitz F; Simader C; Prünte C; Schmidt-Erfurth UM
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1599-605. PubMed ID: 21051733
[TBL] [Abstract][Full Text] [Related]
11. EFFECT OF RANIBIZUMAB AND AFLIBERCEPT ON RETINAL PIGMENT EPITHELIAL DETACHEMENT, SUBRETINAL AND INTRARETINAL FLUID IN AGE-RELATED MACULAR DEGENERATION.
Sumarová P; Ovesná P; Matušková V; Beránek J; Michalec M; Michalcová L; Autrata D; Vysloužilová D; Chrapek O
Cesk Slov Oftalmol; 2022; 78(4):176-185. PubMed ID: 35922146
[TBL] [Abstract][Full Text] [Related]
12. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
[TBL] [Abstract][Full Text] [Related]
13. Radial versus raster spectral-domain optical coherence tomography scan patterns for detection of macular fluid in neovascular age-related macular degeneration.
Adam MK; Rayess N; Rahimy E; Maguire JI; Hsu J
Br J Ophthalmol; 2016 Apr; 100(4):491-4. PubMed ID: 26261232
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Subretinal Hyperreflective Material Reflectivity and Volume in Patients With Neovascular Age-Related Macular Degeneration Following Anti-Vascular Endothelial Growth Factor Treatment.
Charafeddin W; Nittala MG; Oregon A; Sadda SR
Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):523-30. PubMed ID: 26057755
[TBL] [Abstract][Full Text] [Related]
15. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
[TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography.
Shin JY; Woo SJ; Ahn J; Park KH
Korean J Ophthalmol; 2013 Dec; 27(6):425-32. PubMed ID: 24311928
[TBL] [Abstract][Full Text] [Related]
17. Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration.
Gigon A; Iskandar A; Kasser S; Naso S; Zola M; Mantel I
Eye (Lond); 2024 May; 38(7):1342-1348. PubMed ID: 38279038
[TBL] [Abstract][Full Text] [Related]
18. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
Moyal L; Cohen SY; Pedinielli A; Semoun O; Lalloum F; Jung C; Souied E
J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
[TBL] [Abstract][Full Text] [Related]
19. Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration.
Zinkernagel MS; Wolf S; Ebneter A
Ophthalmologica; 2016; 235(1):42-8. PubMed ID: 26540259
[TBL] [Abstract][Full Text] [Related]
20. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]